A Meta-Analysis on Prehypertension and Chronic Kidney Disease
Open Access
- 1 June 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (6) , e0156575
Abstract
Recent studies have demonstrated that there is an association between prehypertension and an increased risk of end-stage renal disease. However, there is conflicting evidence regarding the relationship between prehypertension and chronic kidney disease (CKD). This meta-analysis aimed to demonstrate the association between prehypertension and the incidence of CKD and identify the impacts of gender and ethnic differences. MEDLINE, EMBASE, Cochrane Library (from inception through March 2016) and article reference lists were searched for relevant studies regarding blood pressure and CKD. Blood pressure (BP) measurements were classified as follows: optimal BP (less than 120/80 mmHg), prehypertension (120-139/80-89 mmHg) and hypertension (over 140/90 mmHg). CKD was defined by estimated glomerular filtration rate (eGFR)2 or proteinuria. Two investigators independently extracted the data and assessed the quality of studies enrolled in this meta-analysis using the Newcastle-Ottawa Scale (NOS). We performed the meta-analysis using Stata/SE 12.0 (StataCorp LP). The random-effect models were used in the heterogeneous analyses. After retrieving data from 4,537 potentially relevant articles, we identified 7 cohort studies including 261,264 subjects, according to the predefined selection criteria. Five studies were conducted in Mongolians from East Asia, and the other two studies were performed in Indo-Europeans from Austria and Iran. The participants ranged in age from 20 to 89 years, and the proportion of females ranged from 27.2% to 63.8%. The follow-up period ranged from 2 to 11 years. Compared with the optimal BP values, prehypertension showed an increased risk of CKD (pooled RR = 1.28; 95% CI = 1.13–1.44; P = 0.000; I2 = 77.9%). In the sex-stratified analysis, we found a similar trend in women (pooled RR = 1.29; 95% CI = 1.01–1.63; P = 0.039; I2 = 76.1%) but not in men. This effect was observed only in Mongolians from East Asia (pooled RR = 1.37; 95% CI = 1.18–1.59; P = 0.000; I2 = 81.3%) and not in Indo-Europeans. Prehypertension is considered a potential cause of CKD. Gender and ethnic differences are exhibited in this association.Keywords
Funding Information
- Key Project of Chinese National Program for Fundamental Research and Development (973 Program) (2012CB517803)
- National Natural Scientific Foundation, China (81170674, 81470937 to C.L)
This publication has 33 references indexed in Scilit:
- New-onset hypertension and risk for chronic kidney disease in the Japanese general populationJournal Of Hypertension, 2014
- Preventing the Progression of Prehypertension to Hypertension: Role of AntihypertensivesCurrent Hypertension Reports, 2014
- Relationship between prehypertension and chronic kidney disease in middle-aged people in Korea: the Korean genome and epidemiology studyBMC Public Health, 2012
- Prehypertension - time to act.2012
- The prevalence and heterogeneity of prehypertension : a meta-analysis and meta-regression of published literature worldwideCardioVascular Journal of Africa, 2012
- The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension LeagueJournal Of Hypertension, 2008
- Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global OutcomesKidney International, 2007
- Feasibility of Treating Prehypertension with an Angiotensin-Receptor BlockerNew England Journal of Medicine, 2006
- The conundrum of increased burden of end-stage renal disease in AsiansKidney International, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003